knowledge -WSS

knowledge

author：knowledge 2025-09-29 19:06:53 - browse：814

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Lung cancer screening guidelines updated for cigarette smokers

focus

WSS

ProMED sees offers of support, but its future remains unclear

Lung cancer is America's deadliest cancer. Yet so few get screened

Inari Medical to buy amputation prevention company LimFlow

Liz Cheney makes 1st public comment since Trump's election interference indictments

Travis Kelce and the trap of celebrity vaccine endorsements

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

focus

knowledge

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Live blog: Hearing on CRISPR

Hollywood unions extend contract negotiations for actors

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ukraine taking heavy casualties 10 weeks into its counteroffensive

BioMarin wins approval for gene therapy to treat hemophilia A

Gene therapy’s promise and the high cost of hope

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: Racing for gene therapy & a pioneering approval

leisure time

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Living with Hashimoto's and celiac disease, and med school, too

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Trump cancels press conference intended to dispute Georgia election interference charges

Key Senate panel to consider PBM, drug pricing reform package

knowledge

focus

focus

hotspot